Aronne, MD, FACP, FTOS, DABOM I am biased because I am one of the authors of this paper, but this must be mentioned because it is a new record: In the SURMOUNT-1 trial, after 3 years of treatment with tirzepatide, we were able to reduce the incidence of diabetes by 94% in people who started with prediabetes
It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any medical condition or disease
and is Director of Global Clinical Trial Partners
Conclusion: A New Frontier in Healthcare In conclusion, Semaglutide represents a paradigm shift in the way we approach health and wellness
If youre following the WeightWatchers GLP-1 Success Program , youll get guidance on how to prioritize those nutrients